As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
June 7, 2019
| By Fred Hutch News Service staff
A new study led by physicians at Fred Hutchinson Cancer Research Center shows that patients with HIV and one of a variety of potentially deadly cancers can be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.
From cover-ups to caffeine, here are some tips for protecting your skin during the summer and all year long
July 2, 2015
| By Dr. Rachel Tompa / Fred Hutch News Service
The how-to’s of skin cancer prevention haven’t changed much in recent years — avoid too much ultraviolet light via sun or tanning beds and take care not to burn or tan — but that message is clearly not reaching enough people, according to Fred Hutch researchers.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.